Coronavirus

Coronavirus

The Pune-based vaccine manufacturer Serum Institute of India (SII) is expecting the results of the clinical trials of the COVID-19 vaccine candidate Covishield by January. "We have started manufacturing the product", the SII’s Executive Director, Suresh Jadhav, said on Saturday, adding that the institute would produce 50 million to 60 million doses of the vaccine candidate developed by AstraZeneca and Oxford University every month from January.

Read more at 
The Hindu

Timeline

.......... .......... .......... .......... ..........
  • .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........
.......... .......... .......... .......... ..........
  • .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........
  • .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........
.......... .......... .......... .......... ..........
  • .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........

In-depth coverage

Read more top Science stories on Crisp